P2X7 deficiency attenuates renal injury in experimental glomerulonephritis

Journal of the American Society of Nephrology

Volumn 20, Issue 6, 2009, Pages 1275-1281

  Taylor, Simon R J ^a   Turner, Clare M ^a   Elliott, James I ^b   McDaid, John ^a   Hewitt, Reiko ^a   Smith, Jennifer ^a   Pickering, Matthew C ^b   Whitehouse, Darren L ^c   Cook, H Terence ^a   Burnstock, Geoffrey ^a   Pusey, Charles D ^a   Unwin, Robert J ^a   Tam, Frederick W K ^a,d  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c The Institute for Bioanalytics LLC   (United States)

^d HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

3 [[5 (2,3 DICHLOROPHENYL) 1H TETRAZOL 1 YL]METHYL]PYRIDINE; A 438079; CREATININE; INTERLEUKIN 1BETA; MONOCYTE CHEMOTACTIC PROTEIN 1; PURINERGIC P2X7 RECEPTOR; PURINERGIC RECEPTOR BLOCKING AGENT; UNCLASSIFIED DRUG; A-438079; PURINERGIC P2 RECEPTOR; PYRIDINE DERIVATIVE; TETRAZOLE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DOSE RESPONSE; DRUG MEGADOSE; DRUG TARGETING; FEMALE; HISTOPATHOLOGY; IMMUNE COMPLEX NEPHRITIS; KIDNEY FUNCTION; KIDNEY INJURY; LOW DRUG DOSE; MACROPHAGE MIGRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEINURIA; RAT; RENAL PROTECTION; WILD TYPE; ANIMAL; DRUG ANTAGONISM; GLOMERULONEPHRITIS; MACROPHAGE; MALE; METABOLISM; MOUSE MUTANT; PATHOPHYSIOLOGY; PHYSIOLOGY;

ANIMALS; FEMALE; GLOMERULONEPHRITIS; MACROPHAGES; MALE; MICE; MICE, KNOCKOUT; PYRIDINES; RATS; RECEPTORS, PURINERGIC P2; TETRAZOLES;

EID: 67449087580     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2008060559     Document Type: Article

References (30)

1. Tam FW: Current pharmacotherapy for the treatment of crescentic glomerulonephritis. Expert Opin Investig Drugs 15: 1353-1369, 2006 (Pubitemid 44615285)
2. Pusey CD, Peters DK: Immunopathology of glomerular and interstitial disease. In: Diseases of the Kidney, edited by Schrier RW, Gottschalk CW, Boston, Little, Brown and Co., 1993, pp 1647-1680
3. Tesch GH, Yang N, Yu H, Lan HY, Foti R, Chadban SJ, Atkins RC, Nikolic-Paterson DJ: Intrinsic renal cells are the major source of interleukin- 1 beta synthesis in normal and diseased rat kidney. Nephrol Dial Transplant 12: 1109-1115, 1997 (Pubitemid 27230543)
4. Lan HY, Nikolic-Paterson DJ, Mu W, Vannice JL, Atkins RC: Interleukin- 1 receptor antagonist halts the progression of established crescentic glomerulonephritis in the rat. Kidney Int 47: 1303-1309, 1995
5. Lan HY, Nikolic-Paterson DJ, Zarama M, Vannice JL, Atkins RC: Suppression of experimental crescentic glomerulonephritis by the interleukin- 1 receptor antagonist. Kidney Int 43: 479-485, 1993 (Pubitemid 23162845)
6. Timoshanko JR, Kitching AR, Iwakura Y, Holdsworth SR, Tipping PG: Contributions of IL-1beta and IL-1alpha to crescentic glomerulonephritis in mice. J Am Soc Nephrol 15: 910-918, 2004 (Pubitemid 38375310)
7. Kitching AR, Turner AL, Wilson GR, Semple T, Odobasic D, Timoshanko JR, O'Sullivan KM, Tipping PG, Takeda K, Akira S, Holdsworth SR: IL-12p40 and IL-18 in crescentic glomerulonephritis: IL-12p40 is the key Th1-defining cytokine chain, whereas IL-18 promotes local inflammation and leukocyte recruitment. J Am Soc Nephrol 16: 2023-2033, 2005 (Pubitemid 41716433)
8. Yang B, Johnson TS, Haylor JL, Wagner B, Watson PF, El Kossi MM, Furness PN, El Nahas AM: Effects of caspase inhibition on the progression of experimental glomerulonephritis. Kidney Int 63: 2050-2064, 2003 (Pubitemid 36605816)
9. North RA: Molecular physiology of P2X receptors. Physiol Rev 82: 1013-1067, 2002
10. MacKenzie A, Wilson HL, Kiss-Toth E, Dower SK, North RA, Surprenant A: Rapid secretion of interleukin-1beta by microvesicle shedding. Immunity 15: 825-835, 2001 (Pubitemid 34008509)
11. Taylor SR, Gonzalez-Begne M, Dewhurst S, Chimini G, Higgins CF, Melvin JE, Elliott JI: Sequential shrinkage and swelling underlie P2X7- stimulated lymphocyte phosphatidylserine exposure and death. J Immunol 180: 300-308, 2008
12. Sikora A, Liu J, Brosnan C, Buell G, Chessel I, Bloom BR: Cutting edge: Purinergic signaling regulates radical-mediated bacterial killing mechanisms in macrophages through a P2X7-independent mechanism. J Immunol 163: 558-561, 1999 (Pubitemid 29328055)
13. Solle M, Labasi J, Perregaux DG, Stam E, Petrushova N, Koller BH, Griffiths RJ, Gabel CA: Altered cytokine production in mice lacking P2X(7) receptors. J Biol Chem 276: 125-132, 2001 (Pubitemid 32050297)
14. Moore SF, MacKenzie AB: Murine macrophage P2X7 receptors support rapid prothrombotic responses. Cell Signal 19: 855-866, 2007 (Pubitemid 46275375)
15. Baroni M, Pizzirani C, Pinotti M, Ferrari D, Adinolfi E, Calzavarini S, Caruso P, Bernardi F, Di Virgilio F: Stimulation of P2 (P2X7) receptors in human dendritic cells induces the release of tissue factor-bearing microparticles. FASEB J 21: 1926-1933, 2007 (Pubitemid 46855637)
16. Hillman KA, Burnstock G, Unwin RJ: The P2X7 ATP receptor in the kidney: A matter of life or death? Nephron Exp Nephrol 101: e24-e30, 2005 (Pubitemid 41159948)
17. Huang XR, Tipping PG, Apostolopoulos J, Oettinger C, D'Souza M, Milton G, Holdsworth SR: Mechanisms of T cell-induced glomerular injury in anti-glomerular basement membrane (GBM) glomerulonephritis in rats. Clin Exp Immunol 109: 134-142, 1997 (Pubitemid 27293895)
18. Turner CM, Tam FW, Lai PC, Tarzi RM, Burnstock G, Pusey CD, Cook HT, Unwin RJ: Increased expression of the pro-apoptotic ATP-sensitive P2X7 receptor in experimental and human glomerulonephritis. Nephrol Dial Transplant 22: 386-395, 2007 (Pubitemid 46189881)
19. Tarzi RM, Davies KA, Robson MG, Fossati-Jimack L, Saito T, Walport MJ, Cook HT: Nephrotoxic nephritis is mediated by Fcgamma receptors on circulating leukocytes and not intrinsic renal cells. Kidney Int 62: 2087-2096, 2002 (Pubitemid 35366162)
20. Tam FW, Karkar AM, Smith J, Yoshimura T, Steinkasserer A, Kurrle R, Langner K, Rees AJ: Differential expression of macrophage inflamma- tory protein-2 and monocyte chemoattractant protein-1 in experimental glomerulonephritis. Kidney Int 49: 715-721, 1996 (Pubitemid 26093080)
21. Tang WW, Qi M, Warren JS: Monocyte chemoattractant protein 1 mediates glomerular macrophage infiltration in anti-GBM Ab GN. Kidney Int 50: 665-671, 1996 (Pubitemid 26274399)
22. Wada T, Yokoyama H, Furuichi K, Kobayashi KI, Harada K, Naruto M, Su SB, Akiyama M, Mukaida N, Matsushima K: Intervention of crescentic glomerulonephritis by antibodies to monocyte chemotactic and activating factor (MCAF/MCP-1). FASEB J 10: 1418-1425, 1996 (Pubitemid 126785081)
23. Shimizu S, Nakashima H, Masutani K, Inoue Y, Miyake K, Akahoshi M, Tanaka Y, Egashira K, Hirakata H, Otsuka T, Harada M: Anti-monocyte chemoattractant protein-1 gene therapy attenuates nephritis in MRL/ lpr mice. Rheumatology (Oxford) 43: 1121-1128, 2004 (Pubitemid 39232817)
24. McGaraughty S, Chu KL, Namovic MT, Donnelly-Roberts DL, Harris RR, Zhang XF, Shieh CC, Wismer CT, Zhu CZ, Gauvin DM, Fabiyi AC, Honore P, Gregg RJ, Kort ME, Nelson DW, Carroll WA, Marsh K, Faltynek CR, Jarvis MF: P2X7-related modulation of pathological nociception in rats. Neuroscience 146: 1817-1828, 2007
25. Goncalves RG, Gabrich L, Rosario A Jr, Takiya CM, Ferreira ML, Chiarini LB, Persechini PM, Coutinho-Silva R, Leite M Jr: The role of purinergic P2X7 receptors in the inflammation and fibrosis of unilateral ureteral obstruction in mice. Kidney Int 70: 1599-1606, 2006 (Pubitemid 44606995)
26. Mukai K, Shibata T, Kato K, Sugisaki T: Adjuvant-induced macrophage- dominant nephrotoxic serum nephritis in rats. Clin Exp Nephrol 9: 15-23, 2005 (Pubitemid 40576879)
27. Chessell IP, Hatcher JP, Bountra C, Michel AD, Hughes JP, Green P, Egerton J, Murfin M, Richardson J, Peck WL, Grahames CB, Casula MA, Yiangou Y, Birch R, Anand P, Buell GN: Disruption of the P2X7 purinoceptor gene abolishes chronic inflammatory and neuropathic pain. Pain 114: 386-396, 2005 (Pubitemid 40385877)
28. Panenka W, Jijon H, Herx LM, Armstrong JN, Feighan D, Wei T, Yong VW, Ransohoff RM, MacVicar BA: P2X7-like receptor activation in astrocytes increases chemokine monocyte chemoattractant protein-1 expression via mitogen-activated protein kinase. J Neurosci 21: 7135-7142, 2001 (Pubitemid 32846961)
29. Robson MG, Cook HT, Botto M, Taylor PR, Busso N, Salvi R, Pusey CD, Walport MJ, Davies KA: Accelerated nephrotoxic nephritis is exacerbated in C1q-deficient mice. J Immunol 166: 6820-6828, 2001 (Pubitemid 32467227)
30. Sheryanna A, Bhangal G, McDaid J, Smith J, Manning A, Foxwell BM, Feldmann M, Cook HT, Pusey CD, Tam FW: Inhibition of p38 mitogen-activated protein kinase is effective in the treatment of experimental crescentic glomerulonephritis and suppresses monocyte chemoattractant protein-1 but not IL-1beta or IL-6. J Am Soc Nephrol 18: 1167-1179, 2007 (Pubitemid 46536903)